The relationship between serum C-reactive protein and daily physical activity in Japanese hypertensive patients

Clinical and Experimental Hypertension

Volumn 32, Issue 8, 2010, Pages 517-522

  Uurtuya, Shuumarjav ^a   Kotani, Kazuhiko ^a   Koibuchi, Harumi ^a   Miyamoto, Michiaki ^a   Kario, Kazuomi ^a   Yamada, Toshiyuki ^a   Taniguchi, Nobuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

blood pressure; exercise; inflammation; lifestyle; vascular health

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; DAILY LIFE ACTIVITY; DRINKING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; SALT INTAKE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; JAPAN; LIFE STYLE; MALE; MIDDLE AGED; MOTOR ACTIVITY; RISK FACTORS;

EID: 79251472495     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2010.496512     Document Type: Article

References (30)

1. Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and subtypes in Japanese population. Circulation 2008;118:2672-2678.
2. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-1297.
3. Chobaian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Classification of Blood Pressure. Hypertension 2003;42:1206-1252.
4. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
5. Pfutzner A, Forst T. High-sensitive C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther 2006;8:28-36.
6. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001;19:857-861.
7. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004;68:297-303.
8. Dickey RA, Janick JJ. Lifestyle modifications in the prevention and treatment of hypertension. Endocr Pract 2001;7:392-399.
9. Appel LJ. Nonpharmacologic therapies that reduce blood pressure: a fresh perspective. Clin Cardiol 1999;22:III1-5.
10. Pinto A, Di Raimondo D, Tuttolomondo A, Fernandez P, Arnao V, Licata G. Twenty-four hour ambulatory blood pressure monitoring to evaluate effect on blood pressure of physical activity in hypertensive patients. Clin J Sport Med 2006;16:238-248.
11. Xu T, Ju Z, Tong W, Hu W, Liu Y, Zhao L, Zhang Y. Relationship of C-reactive protein with hypertension and interactions between increased C-reactive protein and other risk factors on hypertension in Mongolian people, China. Circ J 2008;72:1324-1328.
12. Niskanen L, Laaksonen DE, Nyyssonen K, Punnonen K, Valkonen V, Fuentes R, Tuomainen T, Salonen R, Salonen JT. Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 2004;44:859-865.
13. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001;357:763-767.
14. Onat A, Hergenc G, Dursunoglu D, Ordu S, Can G, Bulur S, Yuksel H. Associations of alcohol consumption with blood pressure, lipoproteins, and subclinical inflammation among Turks. Alcohol 2008;42:593-601.
15. Nakandakare ER, Charf AM, Santos FC, Nunes VS, Ortega K, Lottenberg AM, Mion D JR, Nakano T, Nakajima K, D'Amico EA, Catanozi S, Passarelli M, Quintao EC. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentration in hypertensive patients. Atherosclerosis 2008;200:410-416.
16. Niu K, Hoawa A, Fujita K, Ohmori K, Okutsu M, Kuriyama S, Tsuji I, Nagatomi R. Influence of leisure-time physical activity on the relationship between C-reactive protein and hypertension in a community-based elderly population of Japan: The Tsurugaya project. Hypertens Res 2005;28:747-754.
17. Matthews KA, Sowers MF, Derby CA, Stein E, McMahill HM, Grawford SL, Pasternak RC. Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation. Am Heart J 2005;149:1066-1073.
18. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR, Sternfeld D, Paternak RC, Chae CU, SWAN Investigators. Ethnic difference in C-reactive protein concentrations. Clin Chem 2008;54:1027-1037.
19. Hsieh SD, Yoshinaga H, Muto T, Sakurai Y. Regular physical activity an coronary risk factors in Japanese men. Circulation 1998;97:661-665.
20. z.ast; Power 3:A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
21. Higashi Y, Yoshizumi M. Exercise and endothelial function: role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients. Pharmacol Ther 2004;102:87-96.
22. Borodulin K, Laatikainen T, Salomaa V, Jousilahti P. Association of leisure time physical activity, self-rated physical fitness, and estimated aerobic fitness with serum C-reactive protein among 3, 803 adults. Atherosclerosis 2006;185:381-387.
23. van Gils CH, Peeters P. H. M, Schoenmakers M. C. J, Nijmeijer RM, Onland-Moret NC, van der Schouw YT, Monninkhof EM. Physical activity and endogenous sex hormone levels in postmenopausal women: cross sectional study in the prospect-EPIC cohort. Cancer Epidemiol Biomarkers Prev 2009;18:377-383.
24. Stork S, Bots ML, Grobee DE, van der Schouw YT. Endogenous sex hormone and C-reactive protein in healthy postmenopausal women. J Intern Med 2008;264:245-253.
25. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormone in men aged 40-80 years. Eur J Endocrinol 2003;149:583-589.
26. Van Pottelbergh I, Braeckman L, De Bacquer D, De Backer G, Kaufman JM. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in middle-aged men. Atherosclerosis 2006;166:95-102.
27. Maggio M, Basaria S, Ble A, Laurentani F, Bansinelli S, Ceda GP, Valenti G, Ling SM, Ferrucci L. Correlation between testosterone and the inflammatory marker soluble interleukin-5 receptor in older men. J Clin Endocrinol Metab 2006;91:345-347.
28. Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO. Marcers of inflammation are related to physical activity and fitness in sedentary men with treated hypertension. Am J Hypertens 2006;19:669-675.
29. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study. Diabetes Care 2002;25:2016-2021.
30. Sesso HD, Burging JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and risk of developing hypertension JAMA 2003;290:2945-2951.